US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neumora Therapeutics, Inc.

1.63

+0.11507.59%

Post-market: 1.630.00000.00%19:38 EDT

Volume:499.11K

Turnover:798.29K

Market Cap:306.44M

PE:-1.33

High:1.64

Open:1.51

Low:1.51

Close:1.52

52wk High:3.65

52wk Low:0.8302

Shares:188.00M

Float Shares:116.00M

Volume Ratio:0.45

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2237

EPS(LYR):-1.4501

ROE:-187.11%

ROA:-73.85%

PB:6.88

PE(LYR):-1.12

Loading ...

Overview Company News Filings

Top Neumora Executive Makes Notable Move With Insider Stock Sale

Neumora Chief Operating and Development Officer Aurora Daljit Singh Disposes of USD 135,222.93 in Common Shares

Neumora Therapeutics COO and Chief Development Officer Aurora Daljit Singh Disposes of 242,773 Common Shares Worth USD 377,639.16

Neumora Therapeutics, Inc. (NMRA) Receives a Buy from RBC Capital

Neumora Therapeutics reports Q2 EPS (23c), consensus (24c)

Neumora Therapeutics CEO Paul Berns to switch roles, Joshua Pinto to succeed

Neumora Therapeutics, Inc. (NMRA) Receives a Rating Update from a Top Analyst

Neumora Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Neumora Therapeutics Posts Corporate Presentation on Neuroscience Drug Development Strategy

Neumora Therapeutics Promotes Pinto to CEO

Neumora Therapeutics Q2 EPS $(0.23) Beats $(0.24) Estimate

Benzinga Earnings

Neumora Therapeutics - Appoints Joshua Pinto as President and CEO and Board Member

THOMSON REUTERS

Neumora Therapeutics - Q2 2026 Net Loss $43.10 Mln vs $52.70 Mln in Q2 2025

THOMSON REUTERS

Neumora Therapeutics - Paul L. Berns to Serve as Executive Chair

THOMSON REUTERS

Press Release: Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Neumora Therapeutics Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview

Neumora Therapeutics Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics: Buy Rating Backed by De-Risked NMRA-215 Development and Strengthening NLRP3 Class Thesis

Neumora Therapeutics Plans Q4 IND Filing for Obesity Drug After Repeat Toxicology Study

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NMRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":1.63,"timestamp":1787342400000,"preClose":1.515,"halted":0,"volume":499105,"hourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.63,"latestTime":"19:38 EDT","volume":1364,"amount":2223.325,"timestamp":1787355505580,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07590759075907591,"floatShares":115999999,"shares":188000000,"eps":-1.223678,"marketStatus":"Market Closed","change":0.115,"latestTime":"08-21 16:00:00 EDT","open":1.51,"high":1.64,"low":1.51,"amount":798291.3460985,"amplitude":0.085809,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.223678,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":1.515,"preHourTrading":{"tag":"盘前","latestPrice":1.53,"preClose":1.515,"latestTime":"09:19 EDT","volume":452,"amount":690.6432988,"timestamp":1787318389604,"change":0.015,"changeRate":0.009901,"amplitude":0.012739},"postHourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.63,"latestTime":"19:38 EDT","volume":1364,"amount":2223.325,"timestamp":1787355505580,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.453570099750214,"impliedVol":0.1949,"impliedVolPercentile":0.0159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","floatShares":115999999,"roa":"-73.85%","roe":"-187.11%","lyrEps":-1.450067,"volumeRatio":0.453570099750214,"shares":188000000,"dividePrice":0,"high":1.64,"amplitude":0.085809,"preClose":1.515,"low":1.51,"week52Low":0.83015,"pbRate":"6.88","week52High":3.65,"institutionHeld":0,"latestPrice":1.63,"eps":-1.223678,"divideRate":0,"volume":499105,"delay":0,"ttmEps":-1.223678,"open":1.51,"prevYearClose":1.79,"prevWeekClose":1.6,"prevMonthClose":1.61,"prevQuarterClose":1.7,"fiveDayClose":1.6,"twentyDayClose":1.49,"sixtyDayClose":1.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"NMRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.23,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2026-05-07","symbol":"NMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2026-03-30","symbol":"NMRA","fiscalQuarterEnding":"2025/12","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-11-06","symbol":"NMRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-08-06","symbol":"NMRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4444,"hold":0.1111,"sell":0.1111,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":9,"updateTime":1771387200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMRA","date":"2026-08-21","current":-1.33205,"percent":0.680339,"low":-19.620035,"twenty":-8.610207,"median":-1.734908,"eighty":-1.069031,"high":-0.385538,"avg":-4.839955,"sd":4.928367,"marketCap":284662306},"quantilePoints":[{"date":"2023-09-15","current":-19.620035,"twenty":-19.620035,"median":-19.620035,"eighty":-19.620035,"marketCap":2583134632},{"date":"2023-09-22","current":-12.753675,"twenty":-18.754446,"median":-15.453663,"eighty":-12.753675,"marketCap":1679123396},{"date":"2023-09-28","current":-13.691957,"twenty":-17.415667,"median":-13.628246,"eighty":-12.772209,"marketCap":1802655635},{"date":"2023-10-05","current":-13.813351,"twenty":-16.65135,"median":-13.723658,"eighty":-12.773914,"marketCap":1818638110},{"date":"2023-10-13","current":-11.180579,"twenty":-14.994038,"median":-13.691957,"eighty":-12.763183,"marketCap":1472012710},{"date":"2023-10-20","current":-11.493728,"twenty":-13.94093,"median":-13.080265,"eighty":-11.639864,"marketCap":1513241282},{"date":"2023-10-27","current":-14.254079,"twenty":-14.080107,"median":-13.080265,"eighty":-11.690896,"marketCap":1876663508},{"date":"2023-11-03","current":-10.734234,"twenty":-13.848145,"median":-12.776843,"eighty":-11.493728,"marketCap":1667466680},{"date":"2023-11-10","current":-10.420012,"twenty":-13.826354,"median":-12.7442,"eighty":-11.403032,"marketCap":1618655149},{"date":"2023-11-17","current":-11.79624,"twenty":-13.813351,"median":-12.154821,"eighty":-11.403032,"marketCap":1832439792},{"date":"2023-11-24","current":-11.717599,"twenty":-13.766958,"median":-11.806071,"eighty":-11.438475,"marketCap":1820223526},{"date":"2023-12-01","current":-12.041995,"twenty":-13.704638,"median":-11.815901,"eighty":-11.48267,"marketCap":1870615621},{"date":"2023-12-08","current":-12.26809,"twenty":-13.59002,"median":-11.825731,"eighty":-11.493283,"marketCap":1905737383},{"date":"2023-12-15","current":-14.381583,"twenty":-13.717318,"median":-11.894542,"eighty":-11.493728,"marketCap":2234049513},{"date":"2023-12-22","current":-13.75245,"twenty":-13.821153,"median":-12.041995,"eighty":-11.521564,"marketCap":2136319390},{"date":"2023-12-29","current":-16.848963,"twenty":-14.008036,"median":-12.137729,"eighty":-11.563317,"marketCap":2617334836},{"date":"2024-01-05","current":-16.111698,"twenty":-14.24211,"median":-12.26809,"eighty":-11.573312,"marketCap":2502807349},{"date":"2024-01-12","current":-14.991056,"twenty":-14.660761,"median":-12.728927,"eighty":-11.585874,"marketCap":2328725569},{"date":"2024-01-19","current":-14.411074,"twenty":-14.428768,"median":-12.751722,"eighty":-11.613398,"marketCap":2238630612},{"date":"2024-01-26","current":-14.843603,"twenty":-15.020547,"median":-12.776843,"eighty":-11.648787,"marketCap":2305820071},{"date":"2024-02-02","current":-14.991056,"twenty":-15.264335,"median":-13.370218,"eighty":-11.652719,"marketCap":2328725569},{"date":"2024-02-09","current":-17.1537,"twenty":-15.346909,"median":-13.691957,"eighty":-11.671529,"marketCap":2664672864},{"date":"2024-02-16","current":-18.490607,"twenty":-15.539581,"median":-13.783396,"eighty":-11.691031,"marketCap":2872349373},{"date":"2024-02-23","current":-18.500437,"twenty":-15.932789,"median":-13.819852,"eighty":-11.69454,"marketCap":2873876407},{"date":"2024-03-01","current":-17.330643,"twenty":-16.668088,"median":-13.939224,"eighty":-11.709735,"marketCap":2692159461},{"date":"2024-03-08","current":-12.297819,"twenty":-16.990518,"median":-13.97363,"eighty":-11.717599,"marketCap":2901363004},{"date":"2024-03-15","current":-10.189453,"twenty":-16.81554,"median":-13.826354,"eighty":-11.69454,"marketCap":2403946708},{"date":"2024-03-22","current":-9.414974,"twenty":-16.668088,"median":-13.783396,"eighty":-11.650753,"marketCap":2221227691},{"date":"2024-03-28","current":-8.492333,"twenty":-16.613039,"median":-13.722203,"eighty":-11.579976,"marketCap":2003553733},{"date":"2024-04-05","current":-9.246609,"twenty":-16.364935,"median":-13.534996,"eighty":-11.491504,"marketCap":2181506166},{"date":"2024-04-12","current":-9.435178,"twenty":-16.111698,"median":-12.865966,"eighty":-11.216259,"marketCap":2225994275},{"date":"2024-04-19","current":-7.105005,"twenty":-15.954415,"median":-12.753675,"eighty":-10.606446,"marketCap":1676248365},{"date":"2024-04-26","current":-6.123304,"twenty":-15.846283,"median":-12.728927,"eighty":-10.162515,"marketCap":1444640411},{"date":"2024-05-03","current":-6.231441,"twenty":-15.669339,"median":-12.297819,"eighty":-9.792112,"marketCap":1470152824},{"date":"2024-05-10","current":-6.135514,"twenty":-15.610358,"median":-12.155389,"eighty":-9.435178,"marketCap":1558549450},{"date":"2024-05-17","current":-6.047595,"twenty":-15.433415,"median":-12.120637,"eighty":-9.273547,"marketCap":1536216091},{"date":"2024-05-24","current":-5.846636,"twenty":-15.423584,"median":-11.91675,"eighty":-8.957021,"marketCap":1485168412},{"date":"2024-05-31","current":-6.085275,"twenty":-15.399992,"median":-11.884712,"eighty":-8.469435,"marketCap":1545787530},{"date":"2024-06-07","current":-6.235993,"twenty":-15.362637,"median":-11.806071,"eighty":-7.09423,"marketCap":1584073290},{"date":"2024-06-14","current":-6.248553,"twenty":-15.342977,"median":-11.75692,"eighty":-6.904314,"marketCap":1587263770},{"date":"2024-06-21","current":-5.557759,"twenty":-15.335113,"median":-11.717599,"eighty":-6.419582,"marketCap":1411787373},{"date":"2024-06-28","current":-5.777557,"twenty":-15.335113,"median":-11.707769,"eighty":-6.279953,"marketCap":1467620772},{"date":"2024-07-05","current":-6.129234,"twenty":-15.228947,"median":-11.690896,"eighty":-6.264891,"marketCap":1556954210},{"date":"2024-07-12","current":-7.253346,"twenty":-15.12278,"median":-11.653703,"eighty":-6.277441,"marketCap":1842502165},{"date":"2024-07-15","current":-6.939348,"twenty":-15.110984,"median":-11.648787,"eighty":-6.278697,"marketCap":1762740166},{"date":"2024-08-02","current":-7.931581,"twenty":-15.099188,"median":-11.648787,"eighty":-6.279953,"marketCap":2014788082},{"date":"2024-08-09","current":-6.56038,"twenty":-15.040207,"median":-11.579976,"eighty":-6.279953,"marketCap":1798711865},{"date":"2024-08-16","current":-6.881395,"twenty":-14.991056,"median":-11.493728,"eighty":-6.279953,"marketCap":1886727125},{"date":"2024-08-23","current":-6.712133,"twenty":-14.991056,"median":-11.447336,"eighty":-6.393648,"marketCap":1840319079},{"date":"2024-08-30","current":-6.54287,"twenty":-14.922244,"median":-11.299816,"eighty":-6.436952,"marketCap":1793911032},{"date":"2024-09-06","current":-6.297731,"twenty":-14.859331,"median":-10.957407,"eighty":-6.374465,"marketCap":1726699379},{"date":"2024-09-13","current":-6.904742,"twenty":-14.68632,"median":-10.606446,"eighty":-6.374465,"marketCap":1893128235},{"date":"2024-09-20","current":-7.430039,"twenty":-14.481851,"median":-10.304733,"eighty":-6.410301,"marketCap":2037153206},{"date":"2024-09-27","current":-7.634321,"twenty":-14.416972,"median":-9.973946,"eighty":-6.432454,"marketCap":2093162917},{"date":"2024-10-04","current":-7.905725,"twenty":-14.387481,"median":-9.835887,"eighty":-6.454177,"marketCap":2167575819},{"date":"2024-10-11","current":-8.988421,"twenty":-14.365855,"median":-9.536197,"eighty":-6.471402,"marketCap":2464427288},{"date":"2024-10-18","current":-9.898936,"twenty":-14.275648,"median":-9.492422,"eighty":-6.494727,"marketCap":2714070572},{"date":"2024-10-25","current":-7.587628,"twenty":-14.23812,"median":-9.435178,"eighty":-6.5109,"marketCap":2080360698},{"date":"2024-10-31","current":-7.126534,"twenty":-14.186945,"median":-9.414974,"eighty":-6.517189,"marketCap":1953938778},{"date":"2024-11-08","current":-7.599301,"twenty":-14.11026,"median":-9.329429,"eighty":-6.519524,"marketCap":2083561252},{"date":"2024-11-15","current":-6.430581,"twenty":-14.036864,"median":-9.246609,"eighty":-6.508113,"marketCap":1888648838},{"date":"2024-11-22","current":-5.330396,"twenty":-14.008036,"median":-9.078889,"eighty":-6.434404,"marketCap":1565526710},{"date":"2024-11-29","current":-5.467919,"twenty":-13.980511,"median":-8.972721,"eighty":-6.336098,"marketCap":1605916976},{"date":"2024-12-06","current":-5.313893,"twenty":-13.902792,"median":-8.614876,"eighty":-6.276185,"marketCap":1560679878},{"date":"2024-12-13","current":-5.819979,"twenty":-13.839429,"median":-8.495238,"eighty":-6.248553,"marketCap":1709316057},{"date":"2024-12-20","current":-5.775971,"twenty":-13.821153,"median":-8.377845,"eighty":-6.222869,"marketCap":1696391172},{"date":"2024-12-27","current":-6.238049,"twenty":-13.812967,"median":-8.200475,"eighty":-6.175381,"marketCap":1832102465},{"date":"2025-01-03","current":-1.083682,"twenty":-13.811432,"median":-8.147945,"eighty":-6.157876,"marketCap":318275296},{"date":"2025-01-10","current":-1.303719,"twenty":-13.766574,"median":-7.931581,"eighty":-6.140538,"marketCap":382899721},{"date":"2025-01-17","current":-1.193701,"twenty":-13.753032,"median":-7.891133,"eighty":-6.119668,"marketCap":350587508},{"date":"2025-01-24","current":-1.1882,"twenty":-13.716154,"median":-7.812392,"eighty":-6.085275,"marketCap":348971898},{"date":"2025-01-31","current":-1.056178,"twenty":-13.615504,"median":-7.634321,"eighty":-6.067691,"marketCap":310197242},{"date":"2025-02-07","current":-1.07268,"twenty":-13.546812,"median":-7.564281,"eighty":-5.978405,"marketCap":315044074},{"date":"2025-02-14","current":-0.929656,"twenty":-13.337262,"median":-7.53602,"eighty":-5.966304,"marketCap":273038198},{"date":"2025-02-21","current":-0.940658,"twenty":-13.1053,"median":-7.470895,"eighty":-5.920328,"marketCap":276269419},{"date":"2025-02-28","current":-0.852643,"twenty":-12.883791,"median":-7.424202,"eighty":-5.847483,"marketCap":250419649},{"date":"2025-03-07","current":-1.009931,"twenty":-12.773914,"median":-7.253346,"eighty":-5.800175,"marketCap":246207962},{"date":"2025-03-14","current":-0.930199,"twenty":-12.763183,"median":-7.144044,"eighty":-5.763741,"marketCap":226770492},{"date":"2025-03-21","current":-0.770737,"twenty":-12.752113,"median":-7.105005,"eighty":-5.687956,"marketCap":187895550},{"date":"2025-03-28","current":-0.730871,"twenty":-12.743752,"median":-7.036301,"eighty":-5.574632,"marketCap":178176815},{"date":"2025-04-04","current":-0.564099,"twenty":-12.730087,"median":-6.998128,"eighty":-5.417311,"marketCap":137520105},{"date":"2025-04-11","current":-0.476129,"twenty":-12.580434,"median":-6.945391,"eighty":-5.374404,"marketCap":116074096},{"date":"2025-04-17","current":-0.41859,"twenty":-12.352677,"median":-6.926527,"eighty":-5.321594,"marketCap":102046721},{"date":"2025-04-25","current":-0.497989,"twenty":-12.291873,"median":-6.904742,"eighty":-1.375231,"marketCap":121403202},{"date":"2025-05-02","current":-0.511809,"twenty":-12.245663,"median":-6.881395,"eighty":-1.223405,"marketCap":124772347},{"date":"2025-05-09","current":-0.423699,"twenty":-12.15573,"median":-6.846375,"eighty":-1.1893,"marketCap":103292222},{"date":"2025-05-16","current":-0.417316,"twenty":-12.148314,"median":-6.834702,"eighty":-1.12879,"marketCap":107691766},{"date":"2025-05-23","current":-0.449909,"twenty":-12.121955,"median":-6.75723,"eighty":-1.07488,"marketCap":116102658},{"date":"2025-05-30","current":-0.450473,"twenty":-12.120637,"median":-6.747152,"eighty":-1.061679,"marketCap":116248231},{"date":"2025-06-06","current":-0.507762,"twenty":-12.041995,"median":-6.685868,"eighty":-1.033834,"marketCap":131031991},{"date":"2025-06-13","current":-0.562731,"twenty":-11.924033,"median":-6.5954,"eighty":-0.989998,"marketCap":145217284},{"date":"2025-06-20","current":-0.488895,"twenty":-11.91238,"median":-6.57789,"eighty":-0.951354,"marketCap":126163379},{"date":"2025-06-27","current":-0.501055,"twenty":-11.897527,"median":-6.552046,"eighty":-0.939895,"marketCap":129301288},{"date":"2025-07-03","current":-0.51497,"twenty":-11.882746,"median":-6.531197,"eighty":-0.932192,"marketCap":132892092},{"date":"2025-07-11","current":-0.664396,"twenty":-11.845391,"median":-6.513687,"eighty":-0.915408,"marketCap":171452797},{"date":"2025-07-18","current":-1.071809,"twenty":-11.813935,"median":-6.466558,"eighty":-0.901766,"marketCap":276588946},{"date":"2025-07-25","current":-1.435347,"twenty":-11.800172,"median":-6.430581,"eighty":-0.91143,"marketCap":370402741},{"date":"2025-08-01","current":-1.228506,"twenty":-11.772648,"median":-6.345689,"eighty":-0.913154,"marketCap":317025927},{"date":"2025-08-08","current":-1.05869,"twenty":-11.733327,"median":-6.279953,"eighty":-0.915408,"marketCap":266884071},{"date":"2025-08-15","current":-1.015014,"twenty":-11.717599,"median":-6.27111,"eighty":-0.917957,"marketCap":255873774},{"date":"2025-08-22","current":-1.053558,"twenty":-11.711701,"median":-6.248553,"eighty":-0.922507,"marketCap":265590500},{"date":"2025-08-29","current":-1.130648,"twenty":-11.697847,"median":-6.240161,"eighty":-0.927824,"marketCap":285023951},{"date":"2025-09-05","current":-1.047134,"twenty":-11.691098,"median":-6.234271,"eighty":-0.929873,"marketCap":263971046},{"date":"2025-09-12","current":-1.066407,"twenty":-11.688352,"median":-6.217154,"eighty":-0.931528,"marketCap":268829408},{"date":"2025-09-19","current":-1.00859,"twenty":-11.674168,"median":-6.167847,"eighty":-0.932308,"marketCap":254254320},{"date":"2025-09-26","current":-1.092103,"twenty":-11.654686,"median":-6.150338,"eighty":-0.934175,"marketCap":275307225},{"date":"2025-10-03","current":-1.143496,"twenty":-11.648787,"median":-6.138654,"eighty":-0.935832,"marketCap":288262860},{"date":"2025-10-10","current":-1.252707,"twenty":-11.625195,"median":-6.129234,"eighty":-0.937276,"marketCap":315793582},{"date":"2025-10-17","current":-1.143496,"twenty":-11.585874,"median":-6.098338,"eighty":-0.939018,"marketCap":288262860},{"date":"2025-10-24","current":-1.483976,"twenty":-11.573312,"median":-6.085275,"eighty":-0.940658,"marketCap":374093936},{"date":"2025-10-31","current":-1.882272,"twenty":-11.535481,"median":-6.072715,"eighty":-0.944448,"marketCap":474500101},{"date":"2025-11-07","current":-1.768195,"twenty":-11.493728,"median":-6.047595,"eighty":-0.950132,"marketCap":417819201},{"date":"2025-11-14","current":-1.902139,"twenty":-11.492838,"median":-5.97813,"eighty":-0.950743,"marketCap":449469716},{"date":"2025-11-21","current":-1.668791,"twenty":-11.473837,"median":-5.972235,"eighty":-0.95386,"marketCap":394330309},{"date":"2025-11-28","current":-1.583937,"twenty":-11.438475,"median":-5.963003,"eighty":-0.958453,"marketCap":374279615},{"date":"2025-12-05","current":-1.608686,"twenty":-11.3991,"median":-5.921482,"eighty":-0.963621,"marketCap":380127734},{"date":"2025-12-12","current":-1.488688,"twenty":-11.349949,"median":-5.869128,"eighty":-0.966191,"marketCap":351772572},{"date":"2025-12-19","current":-1.236978,"twenty":-11.209123,"median":-5.84706,"eighty":-0.976733,"marketCap":292294118},{"date":"2025-12-26","current":-1.301703,"twenty":-11.180579,"median":-5.82548,"eighty":-0.977791,"marketCap":307588578},{"date":"2026-01-02","current":-1.28732,"twenty":-10.823503,"median":-5.782265,"eighty":-0.97889,"marketCap":304189809},{"date":"2026-01-09","current":-1.675673,"twenty":-10.734234,"median":-5.771277,"eighty":-0.987831,"marketCap":395956567},{"date":"2026-01-16","current":-1.531839,"twenty":-10.632004,"median":-5.730809,"eighty":-0.990132,"marketCap":361968879},{"date":"2026-01-23","current":-1.510263,"twenty":-10.51228,"median":-5.690707,"eighty":-0.994023,"marketCap":356870726},{"date":"2026-01-30","current":-1.474305,"twenty":-10.431808,"median":-5.626838,"eighty":-0.999937,"marketCap":348373804},{"date":"2026-02-06","current":-1.409579,"twenty":-10.281677,"median":-5.512839,"eighty":-1.00602,"marketCap":333079344},{"date":"2026-02-13","current":-2.337313,"twenty":-10.17329,"median":-5.423912,"eighty":-1.009395,"marketCap":552299933},{"date":"2026-02-20","current":-2.502722,"twenty":-10.087087,"median":-5.390906,"eighty":-1.011964,"marketCap":591385774},{"date":"2026-02-27","current":-2.553064,"twenty":-9.944314,"median":-5.374404,"eighty":-1.018277,"marketCap":603281465},{"date":"2026-03-06","current":-2.157519,"twenty":-9.899493,"median":-5.330396,"eighty":-1.027437,"marketCap":509815323},{"date":"2026-03-13","current":-2.258203,"twenty":-9.891226,"median":-5.316643,"eighty":-1.03397,"marketCap":533606704},{"date":"2026-03-20","current":-1.848275,"twenty":-9.844641,"median":-2.553064,"eighty":-1.034185,"marketCap":436741793},{"date":"2026-03-27","current":-1.790741,"twenty":-9.769472,"median":-2.506318,"eighty":-1.034236,"marketCap":423146718},{"date":"2026-04-02","current":-1.605828,"twenty":-9.718546,"median":-2.484743,"eighty":-1.034286,"marketCap":380465575},{"date":"2026-04-10","current":-1.598144,"twenty":-9.645471,"median":-2.437997,"eighty":-1.035523,"marketCap":378645165},{"date":"2026-04-17","current":-1.536677,"twenty":-9.606931,"median":-2.340909,"eighty":-1.040518,"marketCap":364081890},{"date":"2026-04-24","current":-1.719486,"twenty":-9.518687,"median":-2.301354,"eighty":-1.04071,"marketCap":407394409},{"date":"2026-05-01","current":-1.904543,"twenty":-9.445953,"median":-2.229437,"eighty":-1.041995,"marketCap":451239547},{"date":"2026-05-08","current":-1.495876,"twenty":-9.432484,"median":-2.171903,"eighty":-1.047134,"marketCap":354414867},{"date":"2026-05-15","current":-1.618279,"twenty":-9.420361,"median":-2.157519,"eighty":-1.047134,"marketCap":359895509},{"date":"2026-05-22","current":-1.519703,"twenty":-9.409586,"median":-2.064027,"eighty":-1.047134,"marketCap":337972940},{"date":"2026-05-29","current":-1.544347,"twenty":-9.388035,"median":-2.022348,"eighty":-1.047134,"marketCap":343453582},{"date":"2026-06-05","current":-1.437557,"twenty":-9.385312,"median":-1.929745,"eighty":-1.050677,"marketCap":319704133},{"date":"2026-06-12","current":-1.48298,"twenty":-9.273547,"median":-1.902139,"eighty":-1.053558,"marketCap":329805954},{"date":"2026-06-18","current":-1.274697,"twenty":-9.262772,"median":-1.884704,"eighty":-1.052982,"marketCap":283484893},{"date":"2026-06-26","current":-1.258034,"twenty":-9.249303,"median":-1.881168,"eighty":-1.053558,"marketCap":279779208},{"date":"2026-07-02","current":-1.349679,"twenty":-9.177916,"median":-1.861064,"eighty":-1.05513,"marketCap":300160475},{"date":"2026-07-10","current":-1.374673,"twenty":-9.115941,"median":-1.805124,"eighty":-1.057685,"marketCap":305719002},{"date":"2026-07-17","current":-1.333016,"twenty":-9.073636,"median":-1.796333,"eighty":-1.060483,"marketCap":296454790},{"date":"2026-07-24","current":-1.299691,"twenty":-9.014102,"median":-1.790741,"eighty":-1.061679,"marketCap":289043420},{"date":"2026-07-31","current":-1.374673,"twenty":-8.975861,"median":-1.781172,"eighty":-1.06357,"marketCap":305719002},{"date":"2026-08-07","current":-1.366342,"twenty":-8.932776,"median":-1.776358,"eighty":-1.066407,"marketCap":303866160},{"date":"2026-08-14","current":-1.441324,"twenty":-8.783796,"median":-1.768195,"eighty":-1.066716,"marketCap":320541742},{"date":"2026-08-21","current":-1.338045,"twenty":-8.610207,"median":-1.734908,"eighty":-1.069031,"marketCap":284662306}],"updateTime":1787472412609},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661357215","title":"Top Neumora Executive Makes Notable Move With Insider Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2661357215","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661357215?lang=en_us&edition=fundamental","pubTime":"2026-08-22 10:05","pubTimestamp":1787364307,"startTime":"0","endTime":"0","summary":"New insider activity at Neumora Therapeutics, Inc. ( ($NMRA) ) has taken place on August 21, 2026. Neumora Therapeutics, Inc. reported an insider s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-neumora-executive-makes-notable-move-with-insider-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-neumora-executive-makes-notable-move-with-insider-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661218274","title":"Neumora Chief Operating and Development Officer Aurora Daljit Singh Disposes of USD 135,222.93 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661218274","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661218274?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:11","pubTimestamp":1787353889,"startTime":"0","endTime":"0","summary":"Neumora Chief Operating and Development Officer Aurora Daljit Singh disposes of USD 135,222.93 in common sharesNeumora: Chief Operating and Development Officer Aurora Daljit Singh cut direct common st","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL8bswGc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neumora Chief Operating and Development Officer Aurora Daljit Singh Disposes of USD 135,222.93 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479679","title":"Neumora Therapeutics COO and Chief Development Officer Aurora Daljit Singh Disposes of 242,773 Common Shares Worth USD 377,639.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479679","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479679?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:17","pubTimestamp":1787181471,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics COO and Chief Development Officer Aurora Daljit Singh disposes of 242,773 common shares worth USD 377,639.16Neumora Therapeutics Chief Operating and Development Officer Aurora Dal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL45RSSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neumora Therapeutics COO and Chief Development Officer Aurora Daljit Singh Disposes of 242,773 Common Shares Worth USD 377,639.16","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456490","title":"Neumora Therapeutics, Inc. (NMRA) Receives a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456490","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456490?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:25","pubTimestamp":1787019953,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Buy rating on Neumora Therapeutics, Inc. on August 14 and set a price target of $5.00. The company’...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/neumora-therapeutics-inc-nmra-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/neumora-therapeutics-inc-nmra-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","LU0310800379.SGD","BK4207","LU1267930573.SGD","GSIB","NMRA","LU0029864427.USD","BK4007","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659917738","title":"Neumora Therapeutics reports Q2 EPS (23c), consensus (24c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659917738","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659917738?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:42","pubTimestamp":1786887778,"startTime":"0","endTime":"0","summary":"“We delivered another quarter of disciplined execution against our strategic priorities, advancing key programs across our pipeline and positioning...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-reports-q2-eps-23c-consensus-24c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-reports-q2-eps-23c-consensus-24c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659177339","title":"Neumora Therapeutics CEO Paul Berns to switch roles, Joshua Pinto to succeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2659177339","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659177339?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:42","pubTimestamp":1786887760,"startTime":"0","endTime":"0","summary":"Neumora announced the appointment of Joshua Pinto as president and chief executive officer and a member of the board. Co-founder Paul Berns, will s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-ceo-paul-berns-to-switch-roles-joshua-pinto-to-succeed-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-ceo-paul-berns-to-switch-roles-joshua-pinto-to-succeed-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659312360","title":"Neumora Therapeutics, Inc. (NMRA) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2659312360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659312360?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:35","pubTimestamp":1786725355,"startTime":"0","endTime":"0","summary":"Needham analyst Ami Fadia reiterated a Buy rating on Neumora Therapeutics, Inc. today and set a price target of $5.00. According to TipRanks, Fadia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/neumora-therapeutics-inc-nmra-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/neumora-therapeutics-inc-nmra-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659491401","title":"Neumora Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659491401","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659491401?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:20","pubTimestamp":1786710002,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryNeumora Therapeutics IncNMRA.OQreported a quarterly adjusted loss of 23 cents per share for the quarter ended J","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B0RO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145476","title":"Neumora Therapeutics Posts Corporate Presentation on Neuroscience Drug Development Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145476","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145476?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:27","pubTimestamp":1786706879,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics posts corporate presentation on neuroscience drug development strategyNeumora outlined a pipeline spanning cardiometabolic, neurodegenerative, neuropsychiatric programs, with mult","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1SlZ1B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145782","title":"Neumora Therapeutics Promotes Pinto to CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145782","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145782?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:26","pubTimestamp":1786706760,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics promoted Joshua Pinto to chief executive, about a year after he was named president of the biopharmaceutical company.Pinto succeeds Paul Berns, who will assume the role of executive chairperson of the board.Since joining the company in 2021 as finance chief, Pinto has served in roles of increasing responsibility. His experience in the biotech industry, coupled with his scientific expertise, position him well to lead Neumora, the company said Friday.Neumora also appointed Doron Sagman as its chief medical officer. He brings with him more than two decades of executive leadership experience in clinical development, medical affairs, regulatory strategy and psychiatry.The new appointments came as Neumora narrowed its second-quarter net loss to $43.1 million, or 23 cents a share, from a net loss of $52.7 million, or 33 cents a share, a year earlier.The company said it had $116.8 million in cash and cash equivalents as of June 30, expected to enable the company to fund it","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Neumora Therapeutics Promotes Pinto to CEO","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659459601","title":"Neumora Therapeutics Q2 EPS $(0.23) Beats $(0.24) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659459601","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659459601?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:18","pubTimestamp":1786706323,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 30.3 percent increase over losses of $(0.33) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61204242/neumora-therapeutics-q2-eps-0-23-beats-0-24-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659297143","title":"Neumora Therapeutics - Appoints Joshua Pinto as President and CEO and Board Member","url":"https://stock-news.laohu8.com/highlight/detail?id=2659297143","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659297143?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA6NC1QP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143736","title":"Neumora Therapeutics - Q2 2026 Net Loss $43.10 Mln vs $52.70 Mln in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143736","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143736?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA6NC1QP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143274","title":"Neumora Therapeutics - Paul L. Berns to Serve as Executive Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143274","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143274?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA6NC1QP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145881","title":"Press Release: Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145881","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145881?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"president and chief executive officer and a member of the Board of. Directors. Co-founder Paul L. Berns, will serve as Executive Chair.-- Dr. Pinto has made significant contributions to Neumora since. joining in 2021, having served in roles of increasing","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","NMRA","BK4007","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948005","title":"Neumora Therapeutics Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948005","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948005?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:10","pubTimestamp":1786479005,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics Inc <NMRA.OQ> expected to post a loss of24cents a share - Earnings PreviewNeumora Therapeutics IncNMRA.OQNMRA.Ois expected to  show no change in quarterly revenue when it reports ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44820Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656291399","title":"Neumora Therapeutics Inc Expected to Post a Loss of 24 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656291399","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656291399?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:26","pubTimestamp":1785529565,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics Inc <NMRA.OQ> expected to post a loss of24cents a share - Earnings PreviewNeumora Therapeutics IncNMRA.OQNMRA.Ois expected to  show no change in quarterly revenue when it reports ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X34A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003470","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeutics, Inc. (NMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654003470?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:20","pubTimestamp":1785234017,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-vericel-vcel-sarepta-therapeutics-srpt-and-neumora-therapeutics-inc-nmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-vericel-vcel-sarepta-therapeutics-srpt-and-neumora-therapeutics-inc-nmra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","IE00BJT1NW94.SGD","BK4581","IE00B2B36J28.USD","SRPU","BK4137","LU0128526141.USD","XBI","BK4007","XLV","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4588","LABU","LU0029874061.USD","VCEL","BK4139","IE0009355771.USD","SRPT","IE00BFTCPJ56.SGD","BK4585","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654049818","title":"Neumora Therapeutics: Buy Rating Backed by De-Risked NMRA-215 Development and Strengthening NLRP3 Class Thesis","url":"https://stock-news.laohu8.com/highlight/detail?id=2654049818","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654049818?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:55","pubTimestamp":1785164117,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has maintained their bullish stance on NMRA stock, giving a Buy rating today. Myles Minter has given his Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/neumora-therapeutics-buy-rating-backed-by-de-risked-nmra-215-development-and-strengthening-nlrp3-class-thesis-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/neumora-therapeutics-buy-rating-backed-by-de-risked-nmra-215-development-and-strengthening-nlrp3-class-thesis-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010397","title":"Neumora Therapeutics Plans Q4 IND Filing for Obesity Drug After Repeat Toxicology Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010397","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010397?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:21","pubTimestamp":1785154877,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics  said Monday a repeat safety study of its experimental oral obesity drug, NMRA-215, found no unexpected in-life adverse findings, supporting plans to file an investigational new drug application in the fourth quarter of 2026.The company said it repeated the 13-week rat study after an earlier study reported unexpected findings in five of 142 animals.Neumora said an audit found discrepancies that resulted in critical audit observations in how the earlier study was conducted, and the new results, along with previous studies in rats and dogs, suggest the earlier findings were not caused by NMRA-215.Neumora said its preclinical studies showed NMRA-215 produced weight loss as a monotherapy, increased weight loss when used with semaglutide, and improved markers linked to heart and metabolic health.It added that it expects to begin a Phase 1 clinical trial by the end of 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IND","BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":94,"code":"91000000","status":"200"}]}}